Skip to main content
OpenTrials
Completed

NCT Number: NCT04292717

Deficit-specific Training in Spinal Disorders

Impairments of walking function after spinal cord lesion due to, for example, inflammation, ischemia or trauma are exceptionally diverse. Depending on the size, location and completeness of the spinal cord lesion, gait dysfunction is often multifactorial, arising from weakness of leg muscles, sensory impairments or spasticity. Locomotor function in humans with spinal cord damage can be improved through training. However, there are no evidence-based guidelines for the treatment of gait dysfunctions and no excepted standards of gait training in this large and heterogeneous group of patients. A lack of evidence-based guidance and standardisation prevents the development of optimal training programs for patients with spinal cord damage and rather broad and subjective clinical judgement is applied to determine patient care. Objective and quantitative techniques like three-dimensional (3D) full-body movement analysis capable of identifying the most relevant determinants of gait dysfunction at the single-patient-level are not yet implemented as diagnostic tool to guide physical therapy in this heterogeneous group of patients. The objective of this project is to further advance current clinical locomotor training strategies by applying a deficit-oriented gait training approach based on subject-specific, objective gait profiles gleaned from 3D gait analysis in chronic, mildly to moderately gait-impaired individuals with spinal cord damage due to inflammation (in multiple sclerosis, MS) or with traumatic or ischemic spinal cord injury (SCI; motor incomplete). Within a parallel-group clinical trial, gait impaired subjects will be characterized by detailed kinematic 3D gait analysis and either trained according to their individual deficits or treated with non-specific, standard walking therapy for six weeks. It is hypothesized that individually adapted, deficit-oriented training is superior in improving walking function than purely task-related, ambulatory training in patients with spinal cord damage. This project may pave the way to more efficient training approaches in subjects with spinal cord damage by transferring and implementing modern gait assessment techniques into clinical neurorehabilitation and to move towards individual, patient-tailored locomotor training programs.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-80 years
  • Diagnosis of chronic spinal cord injury (>6 months cervical or thoracic motor incomplete traumatic or non-traumatic (AIS C, D) above T12 or diagnosis of either primary- progressive, secondary-progressive, or relapsing-remitting multiple sclerosis as defined by the revised McDonald criteria for at least 3 months and with at least one spinal cord lesion as verified in clinical MRI images
  • Able to walk without assistance or devices on the treadmill and 10m over ground, but must have impaired walking function as demonstrated by neurological examination.

Exclusion criteria

  • Women who are pregnant or breast feeding
  • Current orthopaedic problems of lower limbs
  • History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
  • History of major pulmonary condition (e.g., chronic obstructive pulmonary disease GOLD II-IV)
  • Current major depression or psychosis
  • MS exacerbation within 3 months prior to the screening or at any time during the screening period
  • Participation in another training study

Treatment and study plan

Gait training

Behavioral

All participants will receive training three times a week for 6 weeks (18 training sessions) at the University Hospital Balgrist, Spinal Cord Injury Centre. Each exercise session will last for 1 hour and will be conducted and supervised by an experienced physical therapist.

Primary outcomes

  1. Six minute walk test (6MWT)

    Time frame: Change from screening at 10 weeks

Secondary outcomes

  1. MS-patients: Expanded disability status scale (EDSS)

    Time frame: Change from screening at 10 weeks

    neurological score, range from 0 to 10, lower values better than higher values

  2. SCI-patients: ISNCSCI by the American Spinal Injury Association (ASIA protocol)

    Time frame: Change from screening at 10 weeks

    Perceptions of light touch (LT) and pinprick (PP) stimuli are scored as 0 for absent, 1 for impaired and 2 for normal (range for sum score for pin prick and light touch: 0-112). Motor function is scored on the Medical Research Council Scale of 0 for total paralysis to 5 for normal strength. Ten muscles are tested bilaterally and individual muscle scores are added together, yielding an ASIA motor score that ranges from 0 to 100. For all assessments higher scores are better than lower scores.

  3. SCI-patients: Walking index for Spinal Cord Injury (WISCI II)

    Time frame: Change from screening at 10 weeks

    Range from 0-20, higher values are better than lower values.

  4. MS-/ SCI-patients: Six-minute walk test (6MWT)

    Time frame: 10 weeks

  5. MS-patients. Timed 25-foot walk (T25FW)

    Time frame: Change from screening at 10 weeks

  6. SCI-patients: Timed 10-meter walk test (10MWT)

    Time frame: Change from screening at 10 weeks

  7. MS-/ SCI-patients: Timed up and go test (TUG)

    Time frame: Change from screening at 10 weeks

  8. MS-/ SCI-patients: Kinematic measures on treadmill

    Time frame: Change from screening at 6 and 10 weeks

    A set of key kinematic parameters will be quantified describing leg, trunk and arm movements during walking on a treadmill including range of motion (in degrees) of hip, knee and ankle joints.

  9. MS-/ SCI-patients: Kinetic measures

    Time frame: Change from screening at 6 and 10 weeks

    A set of key kinetic parameters will be quantified describing forces of weight loading for both feet using pedobarography.

  10. MS-/ SCI-patients: Electromyographic measures

    Time frame: Change from screening at 6 and 10 weeks

    EMG measures include timing of leg muscle activity during walking on treadmill.

  11. MS-/ SCI-patients: 12-item WS for walking function (questionnaire)

    Time frame: Change from baseline at 10 weeks

    Questionnaire, range from 12-60 points, lower values are better than higher values.

  12. MS-/ SCI-patients: Time to swim 10m

    Time frame: Change from baseline at 6 weeks

  13. MS-/ SCI-patients: Kinematic parameters of leg movements during swimming (activity sensors)

    Time frame: Change from baseline at 6 weeks

    A set of key kinematic parameters will be quantified describing leg movements during swimming including range of motion (in degrees) of hip, knee and ankle joints.

  14. MS-/SCI-patients: Spinal Cord Independence Measure (SCIM-III)

    Time frame: Change from screening at 10 weeks

  15. MS-/ SCI-patients: Magnetic resonance imaging (MRI)

    Time frame: Change from baseline at 10 weeks

  16. MS-/ SCI-patients: Magnetic resonance spectroscopy (MRS)

    Time frame: Change from baseline at 10 weeks

  17. MS-/ SCI-patients: over ground gait kinematics during clinical walking tests (activity sensors)

    Time frame: Change from baseline at 10 weeks

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • Swiss National Science Foundation

Registry information

Official study title

Precision Medicine in the Rehabilitation of Locomotor Function: Individual Gait Profiles for Deficit-specific Training Strategies in Spinal Disorders

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Mar 3, 2020
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.